Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb 10;13(2):e231839.
doi: 10.1136/bcr-2019-231839.

An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase

George Chapman  1 , Stephanie Tanner  2
Affiliations
Case Reports

An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase

George Chapman et al. BMJ Case Rep. .

Corrected and republished in

Abstract

A 90-year-old woman is referred six months after a transient ischaemic attack (TIA) with asymptomatic cholestatic liver function test (LFT) derangement. Following the TIA, atorvastatin and clopidogrel therapy are initiated. This is added to pre-existent once daily nifedipine for hypertension. Nifedipine (a weak inhibitor of CYP3A4 and competing substrate) and clopidogrel (a competitive inhibitor of CYP3A4) may have affected the metabolism of atorvastatin, resulting in the elevation of serum alkaline phosphatase levels to over six times the upper limit of normal. More often, statin therapy elevates serum alanine aminotransferase levels. Drug-induced liver injury (DILI) was deemed 'probable' as judged by the Roussel Uclaf Causality Assessment Method score. Statin therapy remains overwhelmingly safe, with benefits outweighing risks in the vast majority. The UK recommended LFT monitoring regime facilitates early recognition of DILI. Case reports are examined where similar drug combinations resulted in severe morbidity and mortality.

Keywords: contraindications and precautions; drug interactions; drugs: gastrointestinal system; liver disease; unwanted effects / adverse reactions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Graphical representation of serum alkaline phosphatase (ALP) and alanine aminotransferase (ALT) levels. Temporal association with pharmacological treatments is shown. Tabulated haematological and biochemical data also presented on the same timescale. CRP, C-reactive protein; Hb, haemoglobin; Plt, platelet count; TIA, transient ischaemic attack; WCC, white cell count.
See this image and copyright information in PMC

References

    1. Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374–80. 10.1016/j.jhep.2011.07.023 - DOI - PubMed
    1. Wallace SJ, Webb GW, Madden RG, et al. Investigation of liver dysfunction: who should we test for hepatitis E? Eur J Gastroenterol Hepatol 2017;29:215–20. 10.1097/MEG.0000000000000781 - DOI - PubMed
    1. Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323–30. 10.1016/0895-4356(93)90101-6 - DOI - PubMed
    1. Causevic-Ramosevac A, Semiz S. Drug interactions with statins. Acta Pharm 2013;63:277–93. 10.2478/acph-2013-0022 - DOI - PubMed
    1. Bhindi R, Ormerod O, Newton J, et al. Interaction between statins and clopidogrel: is there anything clinically relevant? QJM 2008;101:915–25. 10.1093/qjmed/hcn089 - DOI - PubMed

Publication types